Ascletis Pharma Inc. (FRA:2VJ)
Germany · Delayed Price · Currency is EUR 1.690
+0.100 (6.29%)
At close: Nov 28, 2025
Ascletis Pharma Market Cap
Ascletis Pharma has a market cap or net worth of €1.59 billion as of December 1, 2025. Its market cap has increased by 815.06% in one year.
Market Cap
1.59B
Enterprise Value
1.38B
Revenue
280.99K
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.69
Market Cap Chart
Since August 1, 2018, Ascletis Pharma's market cap has decreased from 1.71B to 1.59B, a decrease of -7.01%. That is a compound annual growth rate of -0.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 1.61B | 345.20% |
| Dec 31, 2024 | 361.09M | 104.81% |
| Dec 29, 2023 | 176.31M | -71.49% |
| Dec 30, 2022 | 618.38M | 53.38% |
| Dec 31, 2021 | 403.17M | 21.25% |
| Dec 31, 2020 | 332.50M | -11.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 1, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |